Home › NCT06813430
Non-Contact Low-Frequency Ultrasound Vs Standard LaLonde Protocol for Fingertip Injury Wound Healing
Enhancing Healing With Non-Contact Low-Frequency Ultrasound in Fingertip Amputation Treatment: A Prospective Comparative Cohort Study
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Individuals aged 18 years or older with an acute traumatic fingertip amputation without exposed bone or tendons (Allen 1, Tamai level 1; ICD-10 codes S68.5 and S68.6). Exclusion Criteria: * Patients less than 18 years old, * Injuries involving exposed bone * Those with diagnosis of vascular disease * Individuals with clinical suspicion or diagnosis of infection * Unable to comply with prescribed therapy sessions * Patients undergoing primary closure or surgical intervention * Patients experiencing subsequent trauma following treatment initiation
About the study
The goal of this clinical trial is to compare the efficacy of non-contact low frequency ultrasound in populations sustaining fingertip amputations. The main question it aims to answer is:
• Does non-contact low frequency ultrasound significantly improve patient outcomes in patients sustaining acute fingertip amputations?
Researchers will compare non-contact low frequency ultrasound to a standard Lalonde protocol to answer this questions.
Participants will be randomized one of the two study arms and evaluated by wound care therapy. They will receive cohort appropriate therapy sessions 2-3 times per week with measurement of wound size once per week.
What is being tested
- Non-contact Low Frequency Ultrasound (device)
- Lalonde Protocol (standard of care) (other)
Sponsor: St. Luke's Hospital, Pennsylvania · Participants: 22 · Started: Feb 10, 2025
Contact the study team
- Kristofer Matullo, MD · Phone: 484-526-1735
Official record on ClinicalTrials.gov — NCT06813430
Locations in the U.S.
| Pennsylvania | St. Luke's University Health Network, Bethlehem |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.